LUMC/PJ Futurelab offers three online learning-by-doing courses in Autumn 2024. The courses are for post-graduate biomedical and pharmaceutical professionals currently working in academia, industry, business developers, Knowledge Transfer Offices (KTOs), or regulatory authorities. In these courses, you will be guided by world-renowned experts, including real-time video conferences with teachers and other participants, providing a highly interactive experience.
In addition, the courses give you access to unique tools designed to help you draft a license agreement (the License Agreement Builder), develop the most efficient clinical development program (the Questions Optimizing Calculator), and find the relevant guidelines for your product (the Market Approval Navigator).
For the courses described below, there are a limited number of scholarships available for PhDs and post-docs currently working at a Dutch university, university medical center, research center, or hospital. You can read more below.
Intellectual Property course, starting date: November 4th, 2024
Obtaining a patent is a key step in safeguarding the intellectual property of a new biomedical product and to raise funding for development. In this course you’ll learn the pros and cons of intellectual property, as well as the main do’s and don’ts to help you protect your biomedical invention in a timely manner.
You can register here.
Clinical Development course, starting date: November 4th, 2024
Question-based clinical development (QBCD) can facilitate the design of a rational, efficient development pathway for new biomedical products. In this course, you’ll learn the principles behind QBCD and how it can be applied to real-world R&D projects as we described in the PJ Futurelab paper Integrating scientific considerations into R&D project valuation by De Visser et al., Nature Biotechnology, Jan. 2020, p.14-18.
You can register here.
Market Approval course, starting date: November 4th, 2024
Obtaining market approval is an important step in the development of a new biomedical product. In this course you’ll learn how to find and interpret the relevant regulatory guidelines that will steer you through the development process. Real-world case studies, including the development of a gene therapy product and a fictitious mRNA-based vaccine, are presented to familiarize you with issues that can arise during development, as well as how to assess an Investigational Medicinal Product Dossier (IMPD).
You can register here.
Scholarships available
For courses described above a limited number of scholarships are available for post-graduate biomedical and pharmaceutical professionals )PhDs and post-docs) currently working at a university, university medical center, research center, or hospital in the Netherlands. These scholarships provide a 50% discount off the course fee. For more information, and to apply for a scholarship.
Want to learn more?
For more information about these courses check the attached brochures or visit the website.
Who are we?
Paul Janssen Futurelab is a non-profit education and training initiative of the Leiden University Medical Center in the Netherlands. We develop online and on campus post-graduate courses for professionals working in the life sciences.